利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.039 秒)

    Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin
    1.
    发明授权
    Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin 失效
    与胸腺素，ephrin a受体和纤维调节蛋白同源的多肽和多核苷酸

    公开(公告)号：US06992170B2

    公开(公告)日：2006-01-31

    申请号：US09973424

    申请日：2001-10-09

    申请人： Sudhirdas K. Prayaga ,  Raymond J. Taupier, Jr. ,  Raj Bandaru

    发明人： Sudhirdas K. Prayaga ,  Raymond J. Taupier, Jr. ,  Raj Bandaru

    IPC分类号： C07K14/00 ,  C12P21/06 ,  A61K38/00

    CPC分类号： C07K14/4725 ,  A61K38/00 ,  A61K39/00 ,  A61K48/00 ,  C07K14/57581 ,  C07K14/705

    摘要： Disclosed herein are novel human nucleic acid sequences that have homology to thymosin, ephrin A receptors, proteoglycans and fibromodulin. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving these novel nucleic acids and proteins.

    摘要翻译： 本文公开了与胸腺素，ephrin A受体，蛋白聚糖和纤维调节素具有同源性的新型人核酸序列。 还公开了由这些核酸序列编码的多肽，以及与多肽免疫特异性结合的抗体以及上述多肽，多核苷酸或抗体的衍生物，变体，突变体或片段。 本发明还公开了用于诊断，治疗和预防涉及这些新型核酸和蛋白质的病症的治疗，诊断和研究方法。

    FGF-CX polynucleotide sequences and methods of producing same
    8.
    发明授权
    FGF-CX polynucleotide sequences and methods of producing same 失效
    FGF-CX多核苷酸序列及其生产方法

    公开(公告)号：US07291483B2

    公开(公告)日：2007-11-06

    申请号：US11027948

    申请日：2004-12-30

    申请人： Richard A. Shimkets ,  Sudhirdas K. Prayaga

    发明人： Richard A. Shimkets ,  Sudhirdas K. Prayaga

    IPC分类号： C07K14/50 ,  C12N1/21 ,  C12N5/10 ,  C12N15/18 ,  C12N15/63

    CPC分类号： C07K14/50

    摘要： The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-GX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.

    摘要翻译： 本发明提供了FGF-CX，一种新的分离的多肽，以及编码FGF-CX的多核苷酸和免疫特异性结合FGF-CX或FGF-CX多肽的任何衍生物，变体，突变体或片段的多核苷酸或 抗体。 本发明另外提供了FGF-GX多肽，多核苷酸和抗体用于检测和治疗广泛的病理状态以及其它用途的方法。